Bronchial Neuroendocrine Tumor

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-23
Clinical Trial Update: Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors [Phase 1, Phase 2]
Perspective Therapeutics is recruiting for a Phase 1/Phase 2 study of targeted alpha-particle therapy for advanced SSTR2-positive neuroendoc…